Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHelios Underw Regulatory News (HUW)

Share Price Information for Helios Underw (HUW)

Share Price is delayed by 15 minutes
Get Live Data
214.50    -8.00 (-3.60%)
Bid:
211.00
Ask:
218.00
Spread: 7.00 (3.318%)
Market Cap: £146.53m
HUW Live PriceLast checked at - London Stock Exchange

Intraday Helios Underw Share Chart

Material Capacity Increase

1 Dec 2020 07:00

RNS Number : 0057H
Helios Underwriting Plc
01 December 2020
 

 

Helios Underwriting plc

("Helios" or the "Company")

 

Material Capacity Increase

 

Helios, the unique investment vehicle which acquires and consolidates underwriting capacity at Lloyd's is pleased to announce an update on the Company's capacity portfolio and its value for 2021 year of account.

 

 Nigel Hanbury, Chief Executive of Helios, commented:

"I am delighted that the capacity portfolio will underwrite £110m for the 2021 underwriting year, a 60% increase on the size of the portfolio in January 2019 and an increase in the capacity retained by Helios' shareholders of 183% to £59m."

 

Capacity Update

Helios announces that the underwriting capacity for Helios for the 2021 year of account will be £110m a 60% increase in the capacity underwritten at the start of 2020.

 

Helios - 2021 Year of Account Capacity

£m

Retained

Reinsured

Total

Capacity as at 1st January 2021

58.7

51.5

110.3

Capacity as at 1st January 2020

20.7

48.4

69.1

% Increase

183%

7%

60%

 

Helios will only slightly increase the level of capacity reinsured in 2021 thereby increasing its retained capacity to approximately £59m, an increase of 183% over the retained capacity for 2020 underwriting year. Given the much improved underwriting pricing going into 2021, the prospects for underwriting profitability have substantially improved and this increase in the retained capacity should benefit the Company's shareholders. The reinsurance of the "on-risk" open year of account both mitigates the downside risk and provides the necessary underwriting capital for that proportion of the portfolio.

 

Following the recent announcement of the acquisition of four LLVs, the split of capacity between retained and that reinsured for the current open years of account is as follows:

 

2018 to 2020 Years of Account

 

2018

2019

2020

 

£m

£m

£m

Capacity - Position as at 1st Jan 2020

64.5

61.1

69.1

Retained

26.3

22.1

20.7

Reinsured

38.2

39.0

48.4

Capacity acquired during 2020

 

 

 

Retained

9.8

9.2

10.1

Reinsured

0.0

0.0

0.8

Capacity - Position as at 1st Dec 2020

 

 

 

Retained

36.1

31.3

30.9

Reinsured

38.2

39.0

49.1

 

74.3

70.3

80.0

 

The increased retained capacity on the 2018 to 2020 years of account, substantially "off-risk" underwriting years, is expected to contribute to the recognised future profits of the Company.

 

Capacity Value

The value of the capacity fund as at 31st December 2020 using the weighted average prices of capacity from the 2020 Lloyd's capacity auctions has increased to £30.8m (31st December 2019: £26.3m).

 

 

Capacity

Value of Capacity

 

£m

£m

2020 Capacity at 31 Dec 2019

69.11

26.35

Capacity acquired with LLV's in 2020

10.88

4.93

Capacity revaluation having included pre-emptions

10.69

0.85

Net increase in capacity after disposals at the capacity auction

19.58

-1.30

2021 Capacity at 31 Dec 2020

110.26

30.83

 

 

 

 

2019

2020

Capacity with value

57.84

82.76

Free capacity

11.27

27.49

 

69.11

110.26

 

A summary of the movements in capacity and its value are:

 

Helios acquired five LLVs during 2020 with capacity of £10.9m, which were valued at 2019 capacity prices at £4.9m.

 

The syndicates supported by Helios offered free capacity of £10.7m by way of pre-emptions to support the improved underwriting market. The overall change in average prices from 2019 together with the value of the pre-emptions taken up have increased the value of the portfolio by £0.8m.

 

Helios continued to manage the capacity portfolio discarding unwanted syndicates and taking positions on new syndicates, in particular syndicate 4242 and syndicate 2010, taking additional capacity of £12.8m in total on these two syndicates. In addition, £2.4m of capacity was sold at the auctions to raise additional net cash of £1.3m.

 

 

For further information please contact:

 

Helios Underwriting plc

Nigel Hanbury - Chief Executive 07787 530404 / nigel.hanbury@huwplc.com

Arthur Manners - Chief Financial Officer 07754 965 917

Shore Capital

Robert Finlay/David Coaten 020 7408 4090

 

Buchanan

Helen Tarbet/ Henry Wilson /George Beale 020 7466 5000

 

About Helios

Helios provides a limited liability direct investment into the Lloyd's insurance market and is quoted on the London Stock Exchange's AIM market (ticker: HUW). Helios trades within the Lloyd's insurance market writing approximately £110m of capacity for the 2021 account. The portfolio provides a good spread of business being concentrated in property insurance and reinsurance. For further information please visit www.huwplc.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCDBLFXBFLXFBE
Date   Source Headline
29th May 20257:03 amRNSCompany Announcement
29th May 20257:00 amRNSHelios Underwriting 2024 Preliminary Results
20th May 20257:00 amRNSNotice of Results and Change in Accounting
10th Apr 20253:41 pmRNSDirector Shareholding
9th Apr 202512:22 pmRNSDirector/PDMR Shareholding
8th Apr 20257:02 amRNSShare Repurchase Programme - 2025
8th Apr 20257:00 amRNSNet Asset Value as at 31 December 2024
13th Mar 20257:00 amRNSDirector/PDMR Shareholding
10th Feb 20257:00 amRNSDirectorate Change
18th Dec 20247:00 amRNS2025 Capacity Update
15th Nov 20247:00 amRNSCapacity Value Update
3rd Oct 20242:08 pmRNSInvestor Presentation via Investor Meet Company
30th Sep 20247:00 amRNSGrant of LTIP Awards
27th Sep 20247:00 amRNSHalf Year Results
23rd Sep 20247:00 amRNSTR-1: Notification of major holdings
30th Aug 20247:00 amRNSAppointment of Non-Executive Director
1st Aug 20247:00 amRNSTotal Voting Rights
31st Jul 20247:00 amRNSNet Asset Value as at 31 March 2024
24th Jul 20245:36 pmRNSHolding(s) in Company
23rd Jul 20245:05 pmRNSCompletion of Share Buy-Back
17th Jul 20248:50 amRNSDirector/PDMR Shareholding
12th Jul 20247:00 amRNSIssue of Equity
10th Jul 20247:00 amRNSResults of Scrip Dividend Election
9th Jul 20247:00 amRNSShare Repurchase Programme - 2024
1st Jul 20247:00 amRNSDirectorate Change
28th Jun 202411:25 amRNSResults of Annual General Meeting
28th Jun 20247:00 amRNSAGM Statement
19th Jun 20247:00 amRNSShare Repurchase Programme
17th Jun 20247:00 amRNSGrant of LTIP Awards
14th Jun 20247:00 amRNSScrip Dividend Reference Price
7th Jun 20247:00 amRNSDirectorate Change
4th Jun 20247:00 amRNSPosting of Annual Report and Notice of AGM
3rd Jun 20243:19 pmRNSDirector's Shareholding
30th May 20247:00 amRNSFinal results for the year ended 31 December 2023
22nd Apr 20247:00 amRNSDirectorate Change
25th Mar 20242:53 pmRNSChange of Registered Office
22nd Mar 20247:00 amRNSNAV Update - 31 December 2023
4th Mar 20247:00 amRNSHelios appoints Adhiraj Maitra as COO
1st Feb 20247:00 amRNSTotal Voting Rights
26th Jan 20247:00 amRNSTransaction in Own Shares
25th Jan 20247:00 amRNSTransaction in Own Shares
24th Jan 20247:00 amRNSTransaction in Own Shares
23rd Jan 20247:00 amRNSTransaction in Own Shares
22nd Jan 20247:00 amRNSTransaction in Own Shares
12th Jan 20247:00 amRNSTransaction in Own Shares
11th Jan 20247:00 amRNSTransaction in Own Shares
10th Jan 20247:00 amRNSTransaction in Own Shares
8th Jan 20247:00 amRNSTransaction in Own Shares
4th Jan 20247:00 amRNSTransaction in Own Shares
3rd Jan 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.